Research activityResearch alliancesBiotechnologyPharmacovigilanceScientific publicationsCurrently selected Scientific publications Lead Page Image Image Caption Page ContentCariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial Published: Lancet, March 2017 Quality-adjusted life year difference in patients with predominant negative symptoms of schizophrenia treated with cariprazine and risperidonePublished: Journal of Comparative Effectiveness Research, May 2017 Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studiesPublished: International Clinical Psychopharmacology, July 2017 Complete list of cariprazine publications with hiperlinks
Page Image Image Caption Page ContentCariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial Published: Lancet, March 2017 Quality-adjusted life year difference in patients with predominant negative symptoms of schizophrenia treated with cariprazine and risperidonePublished: Journal of Comparative Effectiveness Research, May 2017 Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studiesPublished: International Clinical Psychopharmacology, July 2017 Complete list of cariprazine publications with hiperlinks
